IORFIDA M[au] - Search Results

Year	Number of Results
2005	1
2007	2
2008	1
2010	4
2011	4
2012	6
2013	4
2014	3
2015	4
2016	1
2017	1
2018	3
2019	1
2020	3
2021	3
2023	1
2024	1
2025	1
2026	2

1

Multidisciplinary management of persistent severe cancer pain: a collaborative European approach.

Dupoiron D, Padilla ML, Iorfida M, Falcon A, Brown MRD, Perruchoud C, Zuidema X, Guardamagna V, Tornero C, Hoefing C, Bagchi S, Van Keulen D, Kortbaoui R, Macarulla T, Di Palma M. Dupoiron D, et al. Among authors: iorfida m. Support Care Cancer. 2025 Nov 1;33(11):1001. doi: 10.1007/s00520-025-09997-3. Support Care Cancer. 2025. PMID: 41174085 Free PMC article.

2

Multicentric breast cancer with heterogeneous histopathology: a multidisciplinary review.

Corso G, Magnoni F, Provenzano E, Girardi A, Iorfida M, De Scalzi AM, Invento A, Colleoni M, Cassano E, Trentin C, Gullo RL, Pravettoni G, Gilardi L, Grana CM, Intra M, Galimberti V, Veronesi P, De Lorenzi F, Leonardi MC. Corso G, et al. Among authors: iorfida m. Future Oncol. 2020 Mar;16(8):395-412. doi: 10.2217/fon-2019-0540. Epub 2020 Feb 6. Future Oncol. 2020. PMID: 32026709 Review.

3

Fulvestrant in Combination with CDK4/6 Inhibitors for HER2- Metastatic Breast Cancers: Current Perspectives.

Iorfida M, Mazza M, Munzone E. Iorfida M, et al. Breast Cancer (Dove Med Press). 2020 Mar 18;12:45-56. doi: 10.2147/BCTT.S196240. eCollection 2020. Breast Cancer (Dove Med Press). 2020. PMID: 32256106 Free PMC article. Review.

4

Timing of adjuvant systemic therapy and radiotherapy after breast-conserving surgery and mastectomy.

Balduzzi A, Leonardi MC, Cardillo A, Orecchia R, Dellapasqua S, Iorfida M, Goldhirsch A, Colleoni M. Balduzzi A, et al. Among authors: iorfida m. Cancer Treat Rev. 2010 Oct;36(6):443-50. doi: 10.1016/j.ctrv.2010.02.019. Epub 2010 Mar 20. Cancer Treat Rev. 2010. PMID: 20304562 Review.

5

Systematic review and meta-analysis of post-progression outcomes in ER+/HER2- metastatic breast cancer after CDK4/6 inhibitors within randomized clinical trials.

Munzone E, Pagan E, Bagnardi V, Montagna E, Cancello G, Dellapasqua S, Iorfida M, Mazza M, Colleoni M. Munzone E, et al. Among authors: iorfida m. ESMO Open. 2021 Dec;6(6):100332. doi: 10.1016/j.esmoop.2021.100332. Epub 2021 Dec 1. ESMO Open. 2021. PMID: 34864350 Free PMC article.

6

Real-world use of multigene signatures in early breast cancer: differences to clinical trials.

Licata L, De Sanctis R, Vingiani A, Cosentini D, Iorfida M, Caremoli ER, Sassi I, Fernandes B, Gianatti A, Guerini-Rocco E, Zambelli C, Munzone E, Simoncini EL, Tondini C, Gentilini OD, Zambelli A, Pruneri G, Bianchini G. Licata L, et al. Among authors: iorfida m. Breast Cancer Res Treat. 2024 May;205(1):39-48. doi: 10.1007/s10549-023-07227-0. Epub 2024 Jan 24. Breast Cancer Res Treat. 2024. PMID: 38265569 Free PMC article.

7

Overview and new strategies in metastatic breast cancer (MBC) for treatment of tamoxifen-resistant patients.

Adamo V, Iorfida M, Montalto E, Festa V, Garipoli C, Scimone A, Zanghì M, Caristi N. Adamo V, et al. Among authors: iorfida m. Ann Oncol. 2007 Jun;18 Suppl 6:vi53-7. doi: 10.1093/annonc/mdm225. Ann Oncol. 2007. PMID: 17591833 Free article. Review.

8

Multigene signatures for early breast cancer in clinical practice: A report of the Lombardy genomic assays for breast cancer working group.

Licata L, Cosentini D, De Sanctis R, Iorfida M, Caremoli ER, Vingiani A, Simoncini EL, Pruneri G, Munzone E, Bianchini G, Zambelli A, Tondini C. Licata L, et al. Among authors: iorfida m. Front Oncol. 2023 Mar 6;13:1081885. doi: 10.3389/fonc.2023.1081885. eCollection 2023. Front Oncol. 2023. PMID: 36950554 Free PMC article.

9

Invasive lobular breast cancer: subtypes and outcome.

Iorfida M, Maiorano E, Orvieto E, Maisonneuve P, Bottiglieri L, Rotmensz N, Montagna E, Dellapasqua S, Veronesi P, Galimberti V, Luini A, Goldhirsch A, Colleoni M, Viale G. Iorfida M, et al. Breast Cancer Res Treat. 2012 Jun;133(2):713-23. doi: 10.1007/s10549-012-2002-z. Epub 2012 Mar 8. Breast Cancer Res Treat. 2012. PMID: 22399188

10

Metronomic Chemotherapy for First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Phase II Trial.

Montagna E, Bagnardi V, Cancello G, Sangalli C, Pagan E, Iorfida M, Mazza M, Mazzarol G, Dellapasqua S, Munzone E, Goldhirsch A, Colleoni M. Montagna E, et al. Among authors: iorfida m. Breast Care (Basel). 2018 Jul;13(3):177-181. doi: 10.1159/000487630. Epub 2018 Apr 26. Breast Care (Basel). 2018. PMID: 30069178 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Results by year